课题基金 / 基金详情

Targeted radiopharmaceuticals to improve cancer diagnosis and treatment

Targeted radiopharmaceuticals to improve cancer diagnosis and treatment
靶向放射性药物改善癌症诊断和治疗
批准号:
334222
负责人:
Benard Francois
金额:
$104.34万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-09-01 至 2022-09-01

项目摘要

项目成果

Benard Francois的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this research is to develop novel imaging and therapeutic agents, which have radioactive tags ("radioisotopes") that bind to markers found specifically at the surface of cancer cells. This allows for them to be delivered to specific cancer
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of second-generation radiopharmaceuticals targeting the C-X-C chemokine receptor 4 for imaging and therapy of hematological cancers
  • 批准号:
    463499
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2022
  • 负责人:
    Benard Francois
  • 依托单位:
Advancing the clinical development of [18F]AMBF3-TATE, a novel imaging probe for neuroendocrine tumours
  • 批准号:
    325063
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.66万
  • 财政年份:
    2015
  • 负责人:
    Benard Francois
  • 依托单位:
Integrating Quantitative Imaging Methods and Genomic Biomarkers to Assess the Therapeutic Response of Cancers
  • 批准号:
    314278
  • 项目类别:
    Operating Grants
  • 资助金额:
    $112.84万
  • 财政年份:
    2014
  • 负责人:
    Benard Francois
  • 依托单位:
Radiometals produced by liquid targets for molecular imaging of cancer
  • 批准号:
    248164
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.6万
  • 财政年份:
    2011
  • 负责人:
    Benard Francois
  • 依托单位:
海外基金